Variant classification and interpretation - workshop report

posted on Thursday, 29th June 2017   |   Not tagged.
Variant classification and interpretation - workshop report

Authors: Dr Sobia Raza, Dr Leila Luheshi, Alison Hall, Dr Emma Baple, Prof Sian Ellard, Dominic McMullan 

The ability of all NHS genetics laboratories to reach a consistent and accurate interpretation of a particular variant is paramount given the potential implications for patient management and safety. Advances in genomic technology have led to an increase in the number of novel variants and genes being analysed creating an urgent need to update variant interpretation guidelines to achieve greater consistency.

Key to driving consistency is the use of a common set of principles and approach to assessing variants, along with closer working between clinical colleagues.

This report, produced by PHG Foundation for the Association for Clinical Genomic Science (ACGS), summarises a recent meeting convened with the aim of achieving national consensus on the principles that should underpin the development of variant classification and interpretation guidelines for use within the UK clinical genomics community. Specifically under consideration was whether and how the American College of Medical Genetics and Genomics (ACMG) sequence variant guidelines should be adopted and implemented.

The meeting was jointly hosted by ACGS, the British Society for Genetic Medicine (BSGM), and the Genomics England core Validation and Feedback GeCIP (Genomics England Clinical Interpretation Partnership) group.

Please also see blog by Dr Sobia Raza of the phg foundation. The draft guidelines mentioned are currently being ratified and will be available soon.


How do I submit a News Item?

If you have ideas, suggestions or news items you can submit your news item by going here. If you have any questions or queries please contact us or email

Related Files

    Latest News

  • ClinGen/ACGS collaboration

    posted 5th February 2018  |  0 Comments

    Association for Clinical Genomic Science (ACGS) has entered into a formal affiliation with the ClinGen Inherited Cardiomyopathy Expert Panel (CMP-EP). We will be working jointly to adapt the ACMG/AMP variant classification guidelines for genes associated with hypertrophic cardiomyopathy (HCM). This work is an extension of the ClinGen CMP-EP's recommendations for MYH7 variant classification. ClinGen and ACGS have a shared goal of developing standardised genomic variant interpretation guidelines for improved patient care. The contribution of genomic and phenotypic data from both groups, as well as collaboration in the decision-making process, represents a first step in global development, acceptance, and use of a common set of specified guidelines.

    Read more